News and feature stories about the Department of Neurology at the Indiana University School of Medicine.
Researchers bring promising Alzheimer’s drug target closer to potential clinical trials
IU School of Medicine researchers aim to develop a new treatment for neurodegeneration by targeting an immune cell-specific gene associated with Alzheimer's disease.
July 14, 2025
AI in Medicine: What is your 'aha' moment?
This column is the third in a four-part series from Taeho Jo, titled "AI in Medicine: From Nobel Discoveries to Clinical Frontiers."
July 11, 2025
IU neurologist's research leads to first FDA-approved drug to treat neurofibromatosis type 1
Patients who participated in the clinical trial of the new therapy not only experienced reduction in NF1 and plexiform neurofibromas tumor volume, but also reported significant improvements in pain severity and overall health-related quality of life.
June 10, 2025
The blood test is for adults 55 and older who exhibit symptoms and is the first of its kind, with more than 90% effectiveness.
June 09, 2025
ALS researcher aims to discover hidden causes of neuromuscular disease on quest for new therapies
ALS Awareness Month: Brian Pierchala, PhD, is growing ALS research at IU School of Medicine through the Motoneuron Club and collaborative science.May 02, 2025
Indiana patients are among the first people in the country to receive new disease-modifying drugs for Alzheimer's disease, contributing to the work of IU School of Medicine researchers actively studying the long-term effects of the treatments.
April 24, 2025
Neurology Annual Reports
Media Inquiries
Media interested in interviewing neurology experts are encouraged to contact the Office of Strategic Communications.